6-(6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-3-((methyl-d3)carbamoyl)pyridazin-1(2H)-yl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Deucravacitinib BMT-334616 Metabolite is a fully characterized chemical compound used as a reference standard of API Deucravacitinib. The standard offered is compliant with regulatory guidelines. Deucravacitinib BMT-334616 Metabolite is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
